Publications by authors named "Chloe Talarmin"

Claim this Profile
Q
Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.
Chloé Talarmin, Steven Kerob, François Cartier, Isabelle Madelaine, Sarah Mukenyi

Cytotherapy· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis